New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > Travere Therapeutics, Inc.
Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq ・ Market Cap: Small
CEO Recent Sales
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 27 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 7 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 106,050 0 / 3,928 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $1,084,597 $0 / $40,170 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $363.96 - $243,360 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
49.35%
DIRECTORS
50.65%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.455 0.295 |
VALUE GINI INDEX Sector Average | 0.438 0.288 |
Travere Therapeutics, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2024-09-10 2024-09-10 | Inrig Jula | Officer | -$8,878 | 684 | $12.98 | -1.09% | 61,949 | -4.67% | N/A | |
2024-09-09 2024-09-05 | ROTE WILLIAM E. | Officer | -$50,538 | 4,387 | $11.52 | -4.94% | 84,455 | -0.16% | N/A | |
2024-09-09 2024-09-05 | REED ELIZABETH E | Officer | -$50,538 | 4,387 | $11.52 | -5.28% | 78,633 | -0.16% | N/A | |
2024-09-09 2024-09-05 | Dube Eric M | Director | -$243,360 | 21,125 | $11.52 | -5.51% | 361,975 | -0.16% | N/A | |
2024-09-09 2024-09-05 | Inrig Jula | Officer | -$25,240 | 2,191 | $11.52 | -3.38% | 62,633 | -0.16% | N/A | |
2024-09-09 2024-09-05 | Heerma Peter | Officer | -$25,240 | 2,191 | $11.52 | -1.99% | 107,958 | -0.16% | N/A | |
2024-09-09 2024-09-05 | Cline Christopher R. | Officer | -$28,685 | 2,490 | $11.52 | -3.23% | 74,595 | -0.16% | N/A | |
2024-09-05 2024-09-04 | Cline Christopher R. | Officer | -$4,888 | 514 | $9.51 | -0.73% | 70,335 | +10.57% | N/A | |
2024-04-12 2024-04-11 | Cline Christopher R. | Officer | -$364 | 54 | $6.74 | -0.08% | 70,849 | -0.78% | -17.43% | |
2024-02-02 2024-01-31 | Dube Eric M | Director | -$166,361 | 19,122 | $8.7 | -5.17% | 350,600 | -2.71% | -0.12% |